• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,359.93 -199.31
( -0.27%)
Global Indices
Nasdaq
49,785.17 59.69
(0.12%)
Dow Jones
7,421.51 -12.33
(-0.17%)
Hang Seng
62,722.92 305.04
(0.49%)
Nikkei 225
10,253.59 -15.84
(-0.15%)
Forex
USD-INR
95.14 0.72
(0.77%)
EUR-INR
111.99 0.76
(0.69%)
GBP-INR
129.47 0.85
(0.66%)
JPY-INR
0.61 0.00
(0.51%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
101.48
442893.24
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.87
 

NACL Industries reports consolidated net loss of Rs 0.86 crore in the March 2026 quarter
May 04,2026
Net Loss of NACL Industries reported to Rs 0.86 crore in the quarter ended March 2026 as against net loss of Rs 50.00 crore during the previous quarter ended March 2025. Sales rose 79.19% to Rs 360.95 crore in the quarter ended March 2026 as against Rs 201.43 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 4.57 crore in the year ended March 2026 as against net loss of Rs 92.13 crore during the previous year ended March 2025. Sales rose 28.35% to Rs 1584.46 crore in the year ended March 2026 as against Rs 1234.52 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales360.95201.43 79 1584.461234.52 28
OPM %3.68-36.67 -6.48-5.09 -
PBDT7.67-86.92 LP 58.98-119.45 LP
PBT-1.19-94.96 99 27.02-148.50 LP
NP-0.86-50.00 98 4.57-92.13 LP